Gene Therapy Market Overview
The Gene Therapy Market research report provides a concise overview of the market drivers, restraints, opportunities, trends, technical advancements, product developments, growth strategies, and prospects. It also encompasses the forecast period. The report evaluates various methods such as mergers and acquisitions, government and corporate transactions, partnerships and collaborations, joint ventures, brand promotions, and product launches. Additionally, it offers a comprehensive analysis of the industry, including key metrics like market size, market share, revenue growth, and CAGR, throughout the forecast period from 2021 to 2029.
For detail insights on this market, request for methodology here @ : https://www.maximizemarketresearch.com/request-sample/85074
Gene Therapy Market Scope
The Maximize Market Research report on the Gene Therapy market primarily emphasizes regional market share data, providing valuable insights for stakeholders to explore investment opportunities in micro markets. It also presents a comprehensive analysis of the competitive landscape, including detailed product offerings from significant competitors. Based on market estimation, the Gene Therapy market is projected to experience consistent growth from 2021 to 2029. The report furnishes information regarding key growth drivers, market dynamics, challenges, and scope, along with conducting PESTAL, PORTER, and SWOT analyses. Furthermore, the research identifies crucial trends that are expected to have a significant impact on business operations.
Segmentation
by Indication
• Acute Lymphoblastic Leukemia (ALL)
• Inherited Retinal Disease
• Large B-cell Lymphoma
• ADA-SCID
• Melanoma (lesions)
• Beta-Thalassemia Major/SCD
• Head & Neck Squamous Cell Carcinoma
• Peripheral Arterial Disease
• Spinal Muscular Atrophy (SMA)
• Others
Acute Lymphoblastic Leukaemia (ALL), Inherited Retinal Disease, Large B-cell Lymphoma, ADA-SCID, Melanoma (lesions), Beta-Thalassemia Major/SCD, Head & Neck Squamous Cell Carcinoma, Peripheral Arterial Disease, Spinal Muscular Atrophy (SMA), and Others are the different indications that the market is divided into. By holding a 41% market share in 2021, the Spinal Muscular Atrophy (SMA) sector is anticipated to maintain its dominance through the year 2029. SMA, one of the most common fatal genetic childhood diseases, affects the muscles. As a gene treatment, Zolgensma (AVXS-101) has proven to be effective in curing SMA and changing the disease's phenotype. In May 2021, the FDA approved Zolgensma, a medication developed by Novartis to address the fundamental cause of SMA.
by Vector Type
• Lentivirus
• AAV
• Retrovirus & gamma Retrovirus
• Modified Herpes Simplex Virus
• Adenovirus
• Non-viral Plasmid Vector
The market is divided into Lentivirus, AAV, Retrovirus & gamma Retrovirus, Modified Herpes Simplex Virus, Adenovirus, and Non-viral Plasmid Vector based on the type of vector used. The AAV segment is anticipated to expand quickly between 2022 and 2029, with a CAGR of 27.9%. In 2021, the AAV sector had the most market share (43%). There will be a huge demand for AAV in the next years because its application has grown dramatically in recent years across several therapeutic disciplines. Their established non-pathogenicity is one of the most important factors influencing their adoption. AAV viral vector-based gene therapy research and development is being conducted by a number of firms, including Dimension Therapeutics, AGTC, Spark Therapeutics, Sangamo Biosciences, Biogen, and AveXis.
For any Queries Linked with the Report, Ask an Analyst @ : https://www.maximizemarketresearch.com/request-sample/85074
Key Players
• REGENXBIO, Inc.
• Bayer
• Oxford BioMedica plc
• Dimension Therapeutics, Inc.
• Bristol-Myers Squibb Company
• SANOFI
• Applied Genetic Technologies Corp
• F. Hoffmann-La Roche Ltd.
• Bluebird Bio, Inc.
• Novartis AG
• Taxus Cardium Pharmaceuticals Group, Inc. (Gene Biotherapeutics)
• UniQure N.V.
• Shire Plc;
• Cellectis S.A.
• Sangamo Therapeutics, Inc.
• Orchard Therapeutics
• Gilead Lifesciences, Inc.
• Benitec Biopharma Ltd.
• Sibiono GeneTech Co., Ltd.
• Shanghai Sunway Biotech Co., Ltd
• Gensight Biologics S.A.
• Transgene
• Calimmune, Inc
• Epeius Biotechnologies Corp
• Astellas Pharma, Inc
• American Gene Technologies
• BioMarin Pharmaceuticals, Inc.
• Human Stem Cell Institute
• Spark Therapeutics LLC
• GlaxoSmithKline
• Voyager Therapeutics
Get Full Report Link: https://www.maximizemarketresearch.com/market-report/global-gene-therapy-market/85074/
Table of content for the Gene Therapy Market includes:
- Global Gene Therapy Market: Research Methodology
- Global Gene Therapy Market: Executive Summary
- Market Overview and Definitions
- Introduction to Global Gene Therapy Market
- Summary
- Key Findings
- Recommendations for Investors
- Recommendations for Market Leaders
- Recommendations for New Market Entry
- Global Gene Therapy Market: Competitive Analysis
- MMR Competition Matrix
- Market Structure by region
- Competitive Benchmarking of Key Players
- Consolidation in the Market
- M&A by region
- Key Developments by Companies
- Market Drivers
- Market Restraints
- Market Opportunities
- Market Challenges
- Market Dynamics
- PORTERS Five Forces Analysis
- PESTLE
- Regulatory Landscape by region
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- South America
- COVID-19 Impact
- Global Gene Therapy Market Segmentation
- Global Gene Therapy Market, by Indication (2022-2029)
- Global Gene Therapy Market, by Vector Type (2022-2029)
- Global Gene Therapy Market, by Delivery Method (2022-2029)
- Global Gene Therapy Market, by Gene Type (2022-2029)
- Regional Gene Therapy Market(2022-2029)
- Regional Gene Therapy Market, by Indication (2022-2029)
- Regional Gene Therapy Market, by Vector Type (2022-2029)
- Regional Gene Therapy Market, by Delivery Method (2022-2029)
- Regional Gene Therapy Market, by Gene Type (2022-2029)
- Regional Gene Therapy Market, by Country (2022-2029)
- Company Profile: Key players
- Company Overview
- Financial Overview
- Global Presence
- Capacity Portfolio
- Business Strategy
- Recent Developments
Regional Analysis
The Gene Therapy Report offers a comprehensive analysis of the prevailing trends, dynamics, and pertinent issues within the Gene Therapy market. It encompasses crucial developments that exert influence on the industry. This report aids in understanding the included information and evaluating the competitive landscape of key companies, as well as assessing Gene Therapy market dynamics and other factors that contribute to shaping current marketing strategies. The report covers various regions, including Europe, North America, Asia-Pacific, the Middle East and Africa, and Latin America.
Key Questions answered in the Gene Therapy Market Report are:
- What is Gene Therapy Market?
- What is the forecast period of the Gene Therapy Market?
- What is the competitive scenario of the Gene Therapy market?
- Which region held the largest market share in the Gene Therapy Market?
- What are the opportunities for the Gene Therapy Market?
- What are the restraining factors in the Gene Therapy market?
- Who are the key players of the Gene Therapy market?
Key offerings:
- Market Share, Size, and Forecast by Revenue|2022-2029
- Market Dynamics- Growth drivers, Restraints, Investment Opportunities, and key trends
- Market Segmentation: A detailed analysis by Gene Therapy
- Landscape- Leading key players and other prominent key players.
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include science and engineering, electronic components, industrial equipment, technology, and communication, cars, and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
+91 96071 95908, +91 9607365656
